BLUEbluebird bio, Inc.

Nasdaq bluebirdbio.com


$ 0.93 $ 0.01 (1.13 %)    

Friday, 26-Apr-2024 15:59:21 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 0.9228
$ 0.92
$ 0.00 x 0
$ 0.00 x 0
$ 0.90 - $ 0.94
$ 0.88 - $ 5.53
5,160,818
na
100.68M
$ 1.16
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2023 09-30-2023 10-Q
2 08-08-2023 06-30-2023 10-Q
3 05-09-2023 03-31-2023 10-Q
4 03-29-2023 12-31-2022 10-K
5 11-07-2022 09-30-2022 10-Q
6 08-04-2022 06-30-2022 10-Q
7 05-09-2022 03-31-2022 10-Q
8 03-04-2022 12-31-2021 10-K
9 11-05-2021 09-30-2021 10-Q
10 08-09-2021 06-30-2021 10-Q
11 05-05-2021 03-31-2021 10-Q
12 02-23-2021 12-31-2020 10-K
13 11-04-2020 09-30-2020 10-Q
14 08-05-2020 06-30-2020 10-Q
15 05-11-2020 03-31-2020 10-Q
16 02-18-2020 12-31-2019 10-K
17 10-31-2019 09-30-2019 10-Q
18 08-01-2019 06-30-2019 10-Q
19 05-03-2019 03-31-2019 10-Q
20 02-21-2019 12-31-2018 10-K
21 11-01-2018 09-30-2018 10-Q
22 08-02-2018 06-30-2018 10-Q
23 05-02-2018 03-31-2018 10-Q
24 02-21-2018 12-31-2017 10-K
25 11-01-2017 09-30-2017 10-Q
26 08-02-2017 06-30-2017 10-Q
27 05-03-2017 03-31-2017 10-Q
28 02-22-2017 12-31-2016 10-K
29 11-02-2016 09-30-2016 10-Q
30 08-03-2016 06-30-2016 10-Q
31 05-04-2016 03-31-2016 10-Q
32 02-25-2016 12-31-2015 10-K
33 11-05-2015 09-30-2015 10-Q
34 08-07-2015 06-30-2015 10-Q
35 05-06-2015 03-31-2015 10-Q
36 02-25-2015 12-31-2014 10-K
37 11-12-2014 09-30-2014 10-Q
38 08-12-2014 06-30-2014 10-Q
39 05-13-2014 03-31-2014 10-Q
40 03-05-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bluebird-bio-announces-receipt-of-expected-notice-from-nasdaq-company-has-60-calendar-days-from-receipt-of-the-notice-or-until-june-24-2024-to-submit-a-plan-to-regain-compliance-with-the-rule

bluebird bio, Inc. (NASDAQ:BLUE) today announced that it received a notice (the "notice") on April 24, 2024 from The Na...

 bluebird-bio-inc-anticipates-it-will-be-delayed-in-filing-its-quarterly-report-on-form-10-q-for-q1-of-2024

- SEC Filing

 rbc-capital-reiterates-sector-perform-on-bluebird-bio-maintains-6-price-target

RBC Capital analyst Luca Issi reiterates bluebird bio (NASDAQ:BLUE) with a Sector Perform and maintains $6 price target.

 wells-fargo-maintains-equal-weight-on-bluebird-bio-lowers-price-target-to-3

Wells Fargo analyst Yanan Zhu maintains bluebird bio (NASDAQ:BLUE) with a Equal-Weight and lowers the price target from $4 t...

 bluebird-bio-q4-sales-780m-may-not-be-comparable-to-1668m-estimate

bluebird bio (NASDAQ:BLUE) reported quarterly sales of $7.80 million which missed the analyst consensus estimate of $16.68 mill...

 earnings-scheduled-for-march-26-2024

Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on reve...

 wedbush-maintains-neutral-on-bluebird-bio-lowers-price-target-to-168

Wedbush maintains bluebird bio (NASDAQ:BLUE) with a Neutral and lowers the price target from $3 to $1.68.

 bluebird-bio-announces-first-outcomes-based-agreement-with-medicaid-for-sickle-cell-disease-gene-therapy

bluebird bio, Inc. (NASDAQ:BLUE) ("bluebird bio") today announced it has signed its first Medicaid outcomes-based agree...

 hsbc-maintains-reduce-on-bluebird-bio-lowers-price-target-to-102

HSBC analyst Morten Herholdt maintains bluebird bio (NASDAQ:BLUE) with a Reduce and lowers the price target from $2.31 to $1...

 why-butterfly-network-shares-are-trading-lower-by-22-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed four...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION